
Invesco FTSE 100 UCITS ETF
Invesco FTSE 100 UCITS ETF (DE:SC0A) Price & Chart
DE:SC0A ETF Chart & Stats
- Day’s Range
- EUR 122.88 - EUR 123.48
- 52-Week Range
- EUR 116.30 - EUR 123.48
- Previous Close
- EUR 123.44
- Volume
- 0
- Average Volume (3M)
- 0
- AUM
- 36.05M
- NAV
- 117.68
- Expense Ratio
- 0.24%
- Holdings Count
- 101
- Beta
- 0.46
- Inception Date
- Mar 31, 2009
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 296,332
- Standard Deviation
- N/A
ETF Overview
Invesco FTSE 100 UCITS ETF
The Invesco FTSE 100 UCITS ETF (ticker: DE:SC0A) is a meticulously crafted financial instrument designed to offer investors precise exposure to the United Kingdom's most influential companies. This exchange-traded fund (ETF) mirrors the performance of the FTSE 100 Index, a benchmark that includes the top 100 companies listed on the London Stock Exchange, renowned for their significant market capitalization and robust financial health. As a Large Cap ETF, it focuses primarily on the giants of the UK market, providing a strategic opportunity for investors to tap into established entities with substantial market influence and stability. The fund's niche within the broad-based investment category positions it as an ideal choice for those seeking to fortify their portfolios with blue-chip stocks that have a track record of resilience and consistent performance. With its emphasis on large-cap stocks, the Invesco FTSE 100 UCITS ETF offers a balanced blend of growth potential and defensive characteristics, making it an attractive option for investors aiming to achieve long-term capital appreciation through exposure to the UK's economic leaders.
- Asset Class
- Equity
- Region
- Europe
- Issuer
- Invesco
- Index Tracked
- FTSE 100
- Ticker Symbol
- DE:SC0A
DE:SC0A ETF News


AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s GRACE-DE study, officially titled “Prospective, Observational, Multicenter, and Multicohort Study of Patients With Gastric Cancer Initiating




DE:SC0A ETF FAQ
What was DE:SC0A’s price range in the past 12 months?
What is the AUM of DE:SC0A?
Is DE:SC0A overvalued?
How many shares outstanding does DE:SC0A have?
DE:SC0A ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| HSBAHsbc Holdings Plc (UK) | 8.86% |
| SHELShell plc (UK) | 8.39% |
| AZNAstraZeneca plc | 8.17% |
| RRRolls-Royce Holdings | 4.46% |
| ULVRUnilever Plc (UK) | 4.06% |
| BATSBritish American Tobacco (UK) | 3.61% |
| BPBP p.l.c. | 3.45% |
| GSKGlaxoSmithKline plc (UK) | 2.96% |
| NGNational Grid (Uk) | 2.46% |
| RIORio Tinto (LSE:RIO) | 2.39% |
| Total | 48.81% |









